Inspire Medical Systems, Inc.
General ticker "INSP" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $4.2B (TTM average)
Inspire Medical Systems, Inc. does not follow the US Stock Market performance with the rate: -16.2%.
Estimated limits based on current volatility of 4.5%: low 132.06$, high 142.05$
Factors to consider:
- Total employees count: 1246 (+23.2%) as of 2024
- US accounted for 96.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Cybersecurity threats, Product liability, Third-party risks, Regulatory and compliance, Demand forecasting
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [124.92$, 230.98$]
- 2025-12-31 to 2026-12-31 estimated range: [119.90$, 223.11$]
Financial Metrics affecting the INSP estimates:
- Negative: with PPE of 108.0 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 4.49
- Negative: negative Industry operating cash flow (median)
- Positive: 0.33 < Operating cash flow per share per price, % of 2.34
- Negative: Investing cash flow per share per price, % of -2.03 <= -0.66
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.21 > 6.04
Short-term INSP quotes
Long-term INSP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $407.86MM | $624.80MM | $802.80MM |
| Operating Expenses | $455.45MM | $665.07MM | $766.72MM |
| Operating Income | $-47.59MM | $-40.27MM | $36.08MM |
| Non-Operating Income | $3.32MM | $20.36MM | $22.37MM |
| Interest Expense | $1.68MM | $0.00MM | $0.02MM |
| R&D Expense | $68.64MM | $116.54MM | $114.13MM |
| Income(Loss) | $-44.27MM | $-19.91MM | $58.45MM |
| Taxes | $0.61MM | $1.25MM | $4.94MM |
| Profit(Loss)* | $-44.88MM | $-21.15MM | $53.51MM |
| Stockholders Equity | $496.01MM | $572.51MM | $689.70MM |
| Inventory | $11.89MM | $33.88MM | $80.12MM |
| Assets | $564.88MM | $676.81MM | $808.38MM |
| Operating Cash Flow | $11.57MM | $24.65MM | $130.25MM |
| Capital expenditure | $9.10MM | $23.63MM | $39.12MM |
| Investing Cash Flow | $-19.60MM | $-294.82MM | $-113.12MM |
| Financing Cash Flow | $235.08MM | $13.95MM | $-52.39MM |
| Earnings Per Share** | $-1.60 | $-0.72 | $1.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.